Pharmaceutical Technology2d
Sodium butyrate [USP] by BioKier for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
Sodium butyrate [USP] is under clinical development by BioKier and currently in Phase II for Type 1 Diabetes (Juvenile Diabetes).
FoodNavigator-Asia29d
Concurrent barley and natto consumption shows obesity prevention promise – study
Among the fermented food choices, responders had notably higher consumption of natto (fermented soybeans) than non-responders. It was found that Butyricicoccus (gut butyrate-producing bacterium) and ...
gut.bmj3d
Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
As butyrate enemas may be beneficial in treating colonic inflammation, we investigated if butyrate promotes this effect by acting on proinflammatory cytokine expression. METHODS Intestinal biopsy ...
gut.bmj1mon
In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis
Dr M A S Chapman, Department of Colorectal Surgery, Good Hope Hospital, Rectory Road, Sutton Coldfield B75 7RR, UK. BACKGROUND Butyrate, a short chain fatty acid produced by bacterial fermentation, is ...
BMJ1mon
Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases
In contrast, the short-chain fatty acid butyrate possesses anti-inflammatory effects. One of the mechanisms involved is inhibition of histone deacetylases (HDACs). Here, we explored the effects of ...